LADENBURG THALMANN FINANCIAL SERVICES INC. - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 162 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is 1.80 and the average weighting 0.2%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q4 2019$516,000
+75.5%
6,448
+65.5%
0.00%
+50.0%
Q3 2019$294,000
-13.0%
3,897
+75.6%
0.00%0.0%
Q2 2019$338,000
+30.0%
2,219
+1.8%
0.00%0.0%
Q1 2019$260,000
+76.9%
2,179
+60.6%
0.00%
+100.0%
Q4 2018$147,000
-50.2%
1,357
-26.0%
0.00%
-50.0%
Q3 2018$295,000
+217.2%
1,833
+46.9%
0.00%
+100.0%
Q2 2018$93,0000.0%1,2480.0%0.00%0.0%
Q1 2018$93,000
-40.0%
1,248
-55.1%
0.00%0.0%
Q4 2017$155,000
-19.7%
2,782
-34.7%
0.00%
-50.0%
Q3 2017$193,000
+227.1%
4,262
+140.9%
0.00%
+100.0%
Q2 2017$59,000
+18.0%
1,769
+3.9%
0.00%0.0%
Q1 2017$50,000
+51.5%
1,702
+41.4%
0.00%
Q4 2016$33,000
-87.8%
1,204
-72.7%
0.00%
-100.0%
Q3 2016$271,000
+191.4%
4,404
-10.0%
0.00%
+300.0%
Q2 2016$93,000
+151.4%
4,892
+158.6%
0.00%0.0%
Q1 2016$37,000
-49.3%
1,892
-0.7%
0.00%0.0%
Q4 2015$73,000
+17.7%
1,9050.0%0.00%0.0%
Q3 2015$62,000
+59.0%
1,905
+49.2%
0.00%0.0%
Q2 2015$39,000
+129.4%
1,2770.0%0.00%
Q1 2015$17,000
+325.0%
1,277
+361.0%
0.00%
Q4 2014$4,000
-33.3%
277
-7.7%
0.00%
Q4 2013$6,0003000.00%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q2 2016
NameSharesValueWeighting ↓
Ghost Tree Capital, LLC 290,000$44,066,0009.14%
Avoro Capital Advisors LLC 1,400,000$212,730,0007.35%
NEXTHERA CAPITAL LP 50,317$7,646,0006.37%
Eventide Asset Management 1,123,000$170,640,0005.19%
RTW INVESTMENTS, LP 604,236$91,814,0004.90%
Casdin Capital, LLC 335,000$50,903,250,0004.76%
Copernicus Capital Management, LLC 30,000$4,559,0004.06%
CADIAN CAPITAL MANAGEMENT, LP 548,500$83,345,0003.76%
Camber Capital Management LP 500,000$75,975,0003.54%
Dynamic Capital Management Ltd 4,677$711,0003.54%
View complete list of SAREPTA THERAPEUTICS INC shareholders